THE ELEVATED MARKERS OF HYPERCOAGULABILITY IN CHILDREN WITH HENOCH–SCHÖNLEIN PURPURA
Authors:
- 1 January 2005
- journal article
- research article
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 22 (1) , 41-48
Abstract
Twenty-eight children with HSP and 79 healthy children were entered into study. Activities of protein C, free- protein S and antithrombin, activated protein C resistance, levels of fibrinogen, D-dimer, thrombin-antithrombin complex (TAT), prothrombin fragments 1+2 (PF1 + 2) and von Willebrand factor antigen (vWAg) and its activity (RiCof), were investigated in acute and recovery phases of HSP and controls. Fibrinogen, D-dimer, TAT, PF1 + 2, vWAg and RiCof levels in patients with HSP during the acute phase were significantly higher than those of recovery phase and of the controls. A significant correlation was detected between severity of disease and TAT, PF1+2, vWAg, D-dimer levels.Keywords
This publication has 13 references indexed in Scilit:
- Pathological haemostasis and ‘prothrombotic state’ in Behçet's diseaseThrombosis Research, 2002
- Laboratory signs of activated coagulation are common in Henoch-Schönlein purpuraPediatric Nephrology, 2001
- Vasculitis in childhoodCurrent Opinion in Rheumatology, 2001
- Henoch-Schönlein Purpura in Children from Northwestern SpainMedicine, 2001
- Platelet Function Analysis in Children with Schönlein-Henoch SyndromeArchives of Medical Research, 2001
- Coagulation and fibrinolysis in cutaneous vasculitisClinics in Dermatology, 1999
- Henoch-Schonlein purpuraArchives of Disease in Childhood, 1999
- von Willebrand factor antigen compared with other factors in vasculitic syndromes.Archives of Disease in Childhood, 1994
- The American College of Rheumatology 1990 criteria for the classification of henoch‐schönlein purpuraArthritis & Rheumatism, 1990
- Activity of blood coagulation Factor XIII as a prognostic indicator in patients with Henoch-Sch nlein purpuraEuropean Journal of Pediatrics, 1987